Gynoxin (Fenticonazole Nitrate)

Gynoxin is indicated for the management of common fungal infections affecting the vagina and vulva.

• Treatment of vulvovaginal candidiasis caused by Candida species.
• Therapy for recurrent vaginal yeast infections when topical treatment is preferred.
• Management of mixed fungal‑bacterial vaginitis where an azole agent is appropriate.
• Adjunctive use after systemic antifungal therapy to reduce local colonization.
• Symptomatic relief of itching, discharge, and irritation associated with yeast overgrowth.
• Prevention of recurrence in patients with a history of frequent yeast infections when used as directed.

The most frequently reported local and systemic reactions to Gynoxin are listed below.

Common

• Mild vaginal irritation or burning sensation.
• Local itching or pruritus.
• Slight increase in vaginal discharge that is watery or milky.
• Temporary discomfort during intercourse.

Serious

• Severe allergic reaction with swelling of the vulva or labia.
• Persistent or worsening vaginal inflammation.
• Signs of systemic hypersensitivity such as rash, fever, or difficulty breathing.

Before using Gynoxin, consider the following precautions to ensure safe and effective treatment.

• Confirm diagnosis of a fungal infection; avoid use for bacterial vaginosis without physician guidance.
• Do not use if you have a known hypersensitivity to fenticonazole or other azole antifungals.
• Discuss use with a healthcare provider if you are pregnant, planning pregnancy, or breastfeeding, as safety data are limited.
• Avoid inserting the product if the vaginal mucosa is severely inflamed, ulcerated, or bleeding.
• Keep the applicator clean and store the medication at room temperature away from moisture.
• Report any unexpected or severe symptoms to a medical professional promptly.

Gynoxin may interact with other medications or substances applied to the vagina; the following categories summarize known considerations.

Avoid

• Concurrent use of other topical azole antifungals, which may increase local irritation.
• Intravaginal douches, soaps, or spermicidal products during treatment, as they can reduce drug efficacy.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) because combined exposure may increase systemic absorption.
• Hormonal contraceptives inserted vaginally, as altered vaginal flora could affect drug distribution.
• Antifungal creams or powders applied to the perineal area, which might cause additive irritation.